FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for sodium oxybate submitted by Hikma Pharmaceuticals USA Inc., marking an additional regulatory action for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy with Cataplexy

Drugs mentioned

• Sodium Oxybate (Sodium Oxybate)

Snippet

SUPPL AP for SODIUM OXYBATE (SODIUM OXYBATE)